Results 201 to 210 of about 114,454,660 (263)
ABSTRACT Aims Chronic kidney disease (CKD) is a major complication of type 2 diabetes mellitus (T2DM), driven in part by oxidative stress and the accumulation of advanced glycation end products (AGEs). Oleanolic acid (OA), a natural triterpene present in olive‐derived matrices, may modulate AGE metabolism.
Aída García‐González +14 more
wiley +1 more source
Gut microbiota: a novel key player in urinary stone formation - from oxalate metabolism to systemic regulation. [PDF]
Wang K, Fan W, Tang Q, Su Q.
europepmc +1 more source
Novel Amino Acid Changes Increase Phosphoenolpyruvate Carboxylase Output in planta
ABSTRACT Characterization of previously reported Arabidopsis mutants with increased aluminum (Al) resistance (alr) resulting from greater release of Al‐chelating malate identified three unique amino acid substitutions that each impacts PHOSPHOENOLPYRUVATE CARBOXYLASE 1, a key anaplerotic carbon fixation enzyme.
Jinrui Sheng +7 more
wiley +1 more source
Multi-omics insights into uric acid metabolism in cardiometabolic disease: from genetics to metabolomics. [PDF]
Ali N.
europepmc +1 more source
Hirudin Attenuates Uric Acid-Induced Renal Tubular Injury via TNFRSF6B-Mediated Suppression of NF-κB Signaling. [PDF]
Zhao Y +8 more
europepmc +1 more source
This graphical abstract summarizes the association between the neutrophil percentage‐to‐albumin ratio (NPAR), renal pathology, and prognosis in biopsy‐confirmed diabetic kidney disease. Higher NPAR was associated with increased renal MPO‐positive neutrophil infiltration, more severe histopathological injury, and poorer renal outcomes.
Yang Li +9 more
wiley +1 more source
Uric Acid and Chronic Kidney Disease. [PDF]
Yadlapalli S, Nekkalapudi DK, Wish JB.
europepmc +1 more source
One Hundred Years of Sulfido Ligand in the Molybdenum Cofactor: New Perspectives
The terminal sulfido ligand in mononuclear molybdoenzymes has been appreciated for almost 125 years, with the characterization of Schardinger's enzyme in cow's milk, now known to be xanthine oxidase, that was isolated in 1902 in Vienna, Austria. The ligand is found in molybdoenzymes identified across all kingdoms of life.
Silke Leimkühler +2 more
wiley +1 more source
SGLT2 Inhibitors in Nephrolithiasis: Emerging Evidence and What Urologists Need to Know. [PDF]
Ivănuță M +5 more
europepmc +1 more source
Epigenetic Mechanism of Heart Failure with Preserved Ejection Fraction (HFpEF). [PDF]
Tyagi SC, Ovechkin AV.
europepmc +1 more source

